Global Cardiac AI Monitoring and Diagnostics Market Size is valued at USD 1.4 Bn in 2024 and is predicted to reach USD 14.8 Bn by the year 2034 at an 27.0% CAGR during the forecast period for 2025-2034.
Artificial intelligence technology helps to improve diagnosis, treatment planning, and patient outcomes. AI can be used for many applications, including image analysis for disease detection & diagnosis, predictive analytics for risk evaluation and earlier intervention, and personalized treatments. In addition, technology can simplify, facilitate and enhance clinical decision-making via real-time data study. The use of AI in cardiology is still in its early stages of development, but the potential benefits are enormous, including improvements in accuracy, efficiency, and patient outcomes.
The global Cardiac AI Monitoring and Diagnostics Market is prominently driven by the rising incidence of cardiovascular disorders and the growing demand for effective & cutting-edge devices. Cardiovascular diseases can be effectively treated if noticed early. Thus, increasing demand for early detection & diagnosis of CVDs is likely to propel business growth in the upcoming years. Moreover, several software companies have adopted strategies such as partnerships, collaborations, acquisitions, funding, and others to improve their overall position in the market.
The Cardiac AI Monitoring and Diagnostics Market is segmented based on product, type, application, and end users. The product segment comprises software and hardware. By type, the market is categorized into imaging, ECG-based, cardiac monitoring, and others. By application, the market has been classified into cardiac arrhythmias, cardiac stroke, ischemic heart disease/CAD, and others. The end users segment is divided into hospitals, diagnostic centers, and other end users.
By type, the ECG-based devices segment is expected to lead the market during the forecast period. ECG-based devices are used to identify various cardiac diseases and help in selecting the best treatment. The ECG (electrocardiogram) device records heartbeats using electric signals and is a non-invasive, painless procedure.
By application, the Ischemic Heart Disease/ CAD segment dominated the Cardiac AI Monitoring and Diagnostics Market in 2022. Coronary artery disease (CAD) is one of the most common types of heart disease and affects a vast number of individuals worldwide. The increasing cases of CAD and cardiac stroke are likely to improve the incorporation of AI in monitoring, diagnosing, and treating coronary artery diseases, which is predicted to enhance market growth.
Based on end-users, the hospital segment is expected to witness the fastest expansion over the projected period. Factors including the rising adoption of Al-based cardiovascular diagnostic & monitoring devices, improved healthcare infrastructure, and the development of favourable reimbursement policies are contributing to the growth of the hospital segment.
In 2022, North America accounted for the highest share of the Cardiac AI Monitoring and Diagnostics Market. The factors such as well-developed healthcare infrastructure, rising adoption of Al-based systems, and the increasing CVD cases in the US are driving the market in North America. In addition, Asia Pacific, due to its improving healthcare facilities and fast adoption of advanced cardiovascular diagnostic & monitoring devices, has recorded an increase in the demand for Cardiac AI Monitoring and Diagnostics Market.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.4 Bn |
|
Revenue Forecast In 2034 |
USD 14.8 Bn |
|
Growth Rate CAGR |
CAGR of 27.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Type, By Application, By End Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Aidoc, Tempus Labs, Canon, Inc., Circle Cardiovascular Imaging Inc., General Electric Company, HeartFlow, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Viz.ai, Ultromics, Ltd., Cathworks, Boston Scientific Corporation, and others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cardiac AI Monitoring and Diagnostics Market Snapshot
Chapter 4. Global Cardiac AI Monitoring and Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Software
5.2.2. Hardware
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
6.2.1. Imaging
6.2.2. ECG-based
6.2.3. Cardiac Monitoring
6.2.4. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Product & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1. Cardiac Arrhythmias
7.2.2. Cardiac Stroke
7.2.3. Ischemic Heart Disease/ CAD
7.2.4. Others
Chapter 8. Market Segmentation 4: By End Users Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End Users:
8.2.1. Hospitals
8.2.2. Diagnostic Centers
8.2.3. Other End Users
Chapter 9. Cardiac AI Monitoring and Diagnostics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.2. North America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
9.1.3. North America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.4. North America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By, End Users, 2021-2034
9.1.5. North America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By Product, 2021-2034
9.2.2. Europe Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
9.2.3. Europe Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Application,2021-2034
9.2.4. Europe Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By End Users,2021-2034
9.2.5. Europe Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By Product, 2021-2034
9.3.2. Asia Pacific Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
9.3.3. Asia Pacific Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.3.4. Asia Pacific Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By End Users, 2021-20
9.3.5. Asia Pacific Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By Product, 2021-2034
9.4.2. Latin America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
9.4.3. Latin America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.4.4. Latin America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By End Users, 2021-2034
9.4.5. Latin America Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By Product, (US$ Million)
9.5.2. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
9.5.3. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.5.4. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) estimates and forecasts By End Users, 2021-2034
9.5.5. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market revenue (US$ Million) By country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Aidoc
10.2.2. Tempus Labs
10.2.3. Canon, Inc.
10.2.4. Circle Cardiovascular Imaging Inc.
10.2.5. General Electric Company
10.2.6. HeartFlow, Inc.
10.2.7. iRhythm Technologies, Inc.
10.2.8. Koninklijke Philips N.V.
10.2.9. Siemens Healthineers AG
10.2.10. Viz.ai
10.2.11. Ultromics, Ltd.
10.2.12. Cathworks
10.2.13. Boston Scientific Corporation
10.2.14. Other Prominent Players
Cardiac AI Monitoring and Diagnostics Market By Product-
Cardiac AI Monitoring and Diagnostics Market By Type-
Cardiac AI Monitoring and Diagnostics Market By Application-
Cardiac AI Monitoring and Diagnostics Market By End Users-
Cardiac AI Monitoring and Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
